effect
control
infect
start
commun
level
outsid
hospit
number
import
initi
although
simpl
necessarili
intens
care
relat
greatest
impact
outcom
infect
includ
provis
adequ
age
appropri
food
breast
feed
drinkabl
water
provis
mosquito
net
shelter
avoid
overcrowd
sanit
prevent
diseas
vaccin
basic
need
requir
mankind
basi
good
health
attain
largest
citi
remot
area
infect
one
commonest
caus
mortal
pediatr
intens
care
unit
picu
mortal
depend
origin
infect
infect
intens
care
unit
divid
occur
outsid
hospit
commun
acquir
occur
within
wall
hospit
beyond
h
admiss
nosocomi
prevent
measur
give
benefit
outsid
insid
hospit
good
hand
wash
good
respiratori
care
practic
judici
use
antibiot
exampl
effect
intervent
reduc
rate
nosocomi
infect
sepsi
compris
admiss
typic
pediatr
intens
care
unit
shock
manag
septic
shock
discuss
elsewher
text
howev
basic
principl
manag
limit
intens
care
unit
treatment
commenc
soon
recognit
septic
process
underway
field
clinic
emerg
depart
ward
commun
hospit
ward
picu
time
identif
ill
access
skill
healthcar
personnel
crucial
step
limit
develop
organ
dysfunct
failur
earli
identif
mean
earli
resuscit
earli
treatment
may
hour
case
day
prior
admiss
picu
earli
recognit
intervent
give
patient
greatest
chanc
surviv
signific
infect
catalog
import
microorgan
diseas
caus
picubacteriafungivirus
signific
viral
infect
picuvir
epidem
pandemicsvir
infect
region
import
dengu
fever
ii
viral
hemorrhag
fever
parasit
infect
picumalaria
shock
syndrom
picustaphylococc
toxic
shock
syndromestreptococc
toxic
shock
syndromenecrot
soft
tissu
infect
anatom
distribut
infect
picuupp
airway
infectionsepiglottitiscrouptrach
lower
respiratori
tract
infectionscommunityacquir
pneumoniabronchiol
cardiac
infectionsmyocarditisinfect
endocarditisinfecti
pericarditiswound
infect
cardiac
surgeri
cn
infectionspurul
meningitisencephalitisademguillainbarr
syndromebotul
infect
immunocompromis
hostneutropeniacellular
immun
deficiencyhumor
immun
deficiencycompl
deficiencyhuman
stem
cell
transplant
hstc
patientssolid
organ
transplant
patientshivaid
picubrief
review
antifung
agent
picubrief
review
antivir
agent
picu
nosocomi
infect
picublood
stream
infectionscentr
venou
access
line
infectionsventil
associ
pneumonia
vap
urinari
tract
infect
uti
wound
infect
infect
control
principl
picusummari
staphylococcu
aureu
pneumonia
dissemin
infectionmulti
site
bone
heart
lung
csf
toxic
shock
syndrom
central
venou
line
cvl
infect
staphylococcu
epidermidi
cvl
infect
streptococcu
pyogen
group
streptococcu
bacteremia
septicemia
necrot
fasciiti
toxic
shock
syndrom
streptococcu
agalactia
group
b
streptococcu
earlyl
onset
group
b
sepsi
neonat
enterococcu
faecali
urinari
tract
infectionsvap
ventil
associ
pneumonia
streptococcu
pneumonia
pneumococcu
bacteremia
septicemia
pneumonia
mening
clostridium
tetani
woundrel
tetanu
neonat
tetanu
develop
world
clostridium
botulinum
flaccid
paralysi
botul
clostridium
perfringen
gangrenesepsistoxin
mediat
diseas
clostridium
difficil
antibiot
associ
diarrhea
pseudomembran
coliti
corynebacterium
diphtheria
diphtheria
unvaccin
listeria
monocytogen
sepsi
mening
neonat
immunocompromis
neisseria
meningitidi
meningococcu
septicemia
mening
neisseria
gonorrhoea
gonococcu
neonat
conjunct
pelvic
inflammatori
diseas
occasion
dissemin
infect
involv
joint
e
coli
klebsiella
pneumonia
enterobact
cloaca
serratia
marcescen
proteu
sp
eg
p
vulgari
p
mirabili
bacteroid
fragili
urinari
tract
infect
sepsi
esp
neonat
debilit
cvl
infect
ventil
associ
pneumonia
vap
mening
neonat
haemophilu
influenza
type
b
nontyp
otiti
media
pneumonia
epiglott
mening
unvaccin
b
pertussi
whoop
cough
older
children
necrotizingcalcifi
pneumonia
cardiovascular
collaps
neonat
pseudomona
aeroginosa
burkholderia
cepacia
stenotrophomona
maltophilia
pneumoniachron
infectioncolon
cystic
fibrosi
patient
patient
tracheotomi
vap
bacteria
tendenc
multipl
antibiot
resist
number
medic
signific
bacteria
period
present
pediatr
intens
care
unit
bacteria
preval
region
elsewher
discuss
chapter
classificationyeast
eg
candida
cryptococcu
sp
mold
filament
fungi
eg
aspergillu
sp
trichophyton
sp
dimorph
fungi
yeast
tissu
grow
vitro
mold
eg
histoplasmosi
candida
c
albican
highest
incid
critic
care
environ
follow
c
parapsilosi
c
tropicali
c
glabrata
c
krusei
local
system
infect
neonat
immunocompromis
children
organ
involv
mucou
membran
larynx
esophagu
brain
eye
lung
heart
kidney
liver
spleen
aspergillu
fumigatu
common
speci
invas
aspergillosi
follow
flavu
nigra
local
system
infect
immunocompromis
children
particularli
post
stem
cell
transplant
children
aml
skin
subcutan
tissu
nasopharynx
lung
brain
virtual
organ
endem
mycosi
histoplasmosi
blastomycosi
pneumon
hepatosplenomegali
fever
children
tcell
dysfunct
hiv
infect
coccidioid
immiti
pneumonia
mening
children
tcell
dysfunct
hiv
infect
cryptococcu
neoforman
pneumonia
mening
children
tcell
dysfunct
hiv
infect
herp
simplex
viru
hsv
type
system
infect
neonat
shock
coagulopathi
sever
liver
failureenceph
hepatitisloc
mouth
esophagu
larynx
lung
heart
liver
kidney
cn
system
diseas
organ
stem
cell
transplant
immunocompromis
patient
cytomegaloviru
cmv
congenit
infect
neonat
system
involvementloc
liver
lung
heart
kidney
gi
cn
eye
system
infect
solid
organ
stem
cell
transplant
well
immunocompromis
patient
epsteinbarr
viru
ebv
infecti
mononucleosisburkitt
lymphoma
xlink
lymphoprolif
disord
xllpd
post
transplant
lymphoprolif
disord
ptld
local
liver
heart
lung
kidney
gi
cn
system
infect
solid
organ
stem
cell
transplant
immunocompromis
children
varicellazost
viru
vzv
chickenpox
complic
pneumonia
enceph
meningoenceph
soft
tissu
necrot
infect
caus
streptococcu
staphylococcu
associ
chickenpox
dissemin
herp
zoster
immunocompromis
children
hydrop
fetali
neonateaplast
crisi
patient
sickl
cell
anemiabon
marrow
failuremyocard
coxsaki
b
echovirusmyocard
pericarditismening
polioviru
type
bulbar
poliomyel
upper
respiratori
infect
pertussislik
syndrom
pneumonia
pharyngoconjunctiv
feveracut
hemorrhag
cystitishepat
meningoenceph
myocarditisloc
liver
heart
lung
kidney
gi
cn
system
infect
organ
stem
cell
transplant
immunocompromis
children
fulmin
hepat
hivaid
hemorrhag
feverenceph
dengueyellow
feverenceph
rabi
marborg
ebola
hemorrhag
fever
influenza
influenza
b
cupper
respiratori
infect
croup
pneumonia
ardsenceph
measl
pneumonia
croup
enceph
subacut
scleros
panenceph
sspe
parainfluenza
bronchiol
pneumonia
croup
mump
parot
enceph
meningoenceph
orchiti
pancreat
rsv
human
metapneumoviru
bronchiol
pneumonia
ard
sar
sever
acut
respiratori
distress
syndrom
servic
treat
acut
unwel
child
adult
risk
overwhelm
epidem
nation
region
plan
need
undertaken
prior
advent
seriou
infect
ever
possibl
exampl
sar
sever
acut
respiratori
syndrom
swine
flu
encapsul
worldwid
pandem
plan
take
lesson
sar
epidem
last
major
term
mortal
influenza
epidem
spanish
flu
preval
hospit
organiz
level
concept
surg
strategi
use
organ
base
conting
plan
deal
larg
number
patient
admit
simultan
ie
mass
trauma
casualti
epidem
case
influenza
sar
relev
intens
care
finit
capac
unit
provid
mechan
ventil
addit
institut
respons
protect
health
care
worker
high
risk
contract
infecti
ill
becom
patient
would
increas
burden
ill
potenti
limit
avail
human
resourc
increas
vascular
permeabl
plasma
leakag
lead
shock
hallmark
sever
dengu
infect
children
high
progress
rise
hematocrit
often
sign
plasma
leakag
drop
platelet
count
less
usual
preced
rise
hematocrit
tachycardia
narrow
puls
pressur
mmhg
prolong
capillari
refil
time
cold
extrem
herald
impend
shock
appropri
treatment
rapidli
initi
hypotens
usual
late
sign
shock
often
occur
day
ill
earli
onset
shock
day
suggest
sever
diseasebleed
skin
mucos
gi
bleedinghepat
ruq
tender
jaundiceencephalopathi
lethargi
restless
coma
seizur
treatment
support
specif
treatment
dengu
infect
effect
treatment
dss
time
aggress
fluid
resuscit
evid
colloid
superior
crystalloid
appropri
use
fluid
resuscit
dss
mortal
drop
steroid
shown
effect
may
role
intraven
immunoglobulin
ivig
plasma
exchang
sever
dengu
infect
hypoglycemia
hyponatremia
avoid
rapidli
correct
present
platelet
count
less
less
associ
bleed
warrant
platelet
transfus
ventil
support
need
noninvas
invas
mechan
ventil
ascit
pleural
effus
uncommon
due
vascular
leak
caus
hemodynam
ventilatori
compromis
collect
drain
renal
dysfunct
may
need
hemofiltrationdialysi
yellow
fever
endem
tropic
africa
part
central
south
america
lifecycl
viru
differ
part
world
mosquito
aegypti
haemagogu
sabeth
monkey
peopl
involv
howev
epidem
mosquitoborn
humantohuman
transmiss
occur
incub
period
day
fever
headach
malais
nausea
vomit
musculoskelet
pain
occur
suddenli
initi
clinic
sign
may
includ
conjunct
flush
skin
rel
bradycardia
case
ill
deterior
develop
shock
system
toxic
gi
bleed
renal
dysfunct
liver
failur
jaundic
encephalopathi
system
bleed
latter
pictur
associ
high
mortal
rate
differenti
diagnosi
includ
viral
hemorrhag
fever
viral
hepat
leptospirosi
malaria
typhu
typhoid
fever
brucellosi
rickettsi
diseas
intox
therapi
support
patient
may
need
intens
care
admiss
hepat
renal
circulatori
failur
recommend
routin
childhood
vaccin
endem
area
children
month
age
vector
control
import
highli
popul
area
reduc
risk
epidem
transmiss
lassa
fever
caus
mani
case
death
year
west
africa
lead
caus
matern
fetal
death
viru
carri
mastomi
huberti
mastomi
erythroleucu
rodent
reservoir
whose
infecti
excret
sourc
human
infect
west
africa
adult
children
earli
ill
includ
fever
malais
headach
musculoskelet
pain
nonspecif
symptom
progress
day
includ
pharyng
cough
chest
pain
diarrhea
vomit
endem
area
purul
pharyng
conjunct
head
neck
edema
mucos
bleed
highli
specif
sign
lassa
fever
sever
case
ill
may
complic
hypovolem
shock
encephalopathi
respiratori
distress
caus
laryng
edema
pleural
effus
pneumon
liver
failur
system
gigu
bleed
myocard
occur
mortal
anecdot
report
use
intraven
ribavirin
critic
ill
children
lassa
fever
treatment
mainli
support
lassa
fever
transmit
person
person
hospit
univers
exposur
precaut
observ
well
contact
droplet
precaut
cchf
caus
nairoviru
famili
bunyavirida
transmit
hyalomma
tick
contact
infecti
bodi
fluid
geograph
distribut
hyalomma
tick
cover
africa
middl
east
mediterranean
area
eastern
russia
west
asia
incub
period
day
ill
onset
abrupt
nonspecif
fever
chill
rigor
intens
headach
gener
muscl
pain
onset
bleed
skin
mucou
membran
gi
tract
usual
occur
day
ill
hepat
liver
failur
circulatori
failur
shock
ard
ensu
mortal
case
treatment
mainli
support
viru
sensit
vitro
ribavirin
agent
use
manag
cchf
variabl
success
valu
immun
plasma
recov
patient
therapeut
purpos
demonstr
although
employ
sever
occas
patient
suspect
confirm
cchf
care
staff
use
ad
droplet
contact
precaut
hfr
caus
old
world
hantavirus
famili
bunyavirida
reservoir
small
rodent
human
infect
percutan
direct
exposur
clinic
ill
abrupt
onset
fever
sever
musculoskelet
pain
renal
failur
system
gi
bleed
circulatori
failur
shock
form
diseas
common
asia
eastern
europ
hantaviru
pulmonari
syndrom
hp
mainli
seen
america
within
h
onset
symptom
patient
develop
degre
hemodynam
instabl
pulmonari
edema
accompani
hypoxemia
full
blown
ard
petechia
head
neck
common
overt
hemorrhag
symptom
treatment
support
surviv
recoveri
usual
rapid
given
earli
cours
ill
intraven
ribavirin
improv
surviv
rate
hfr
hp
steroid
reduc
sever
symptom
increas
surviv
rate
indic
sever
complic
falciparum
malaria
prognost
sign
world
health
organ
impair
conscious
degre
prostrat
jaundic
intract
vomit
parasitemia
nonimmun
individu
level
parasitemia
interpret
light
immun
patient
complic
malaria
manag
sever
malaria
ie
parenter
antimalari
even
though
necessarili
meet
criteria
sever
diseas
detail
manag
review
world
health
organ
defin
cerebr
malaria
unrous
coma
presenc
p
falciparum
parasitemia
caus
encephalopathi
exclud
precis
etiolog
cerebr
malaria
certain
like
caus
sequestr
infect
erythrocyt
condit
high
mortal
like
result
brain
micro
vascular
ischemia
infarct
secondari
cerebr
edema
cerebr
malaria
medic
emerg
requir
support
care
continu
monitor
vital
signsmonitor
serum
electrolyt
glucos
correct
abnorm
result
appropri
therapyseizur
frequent
requir
suppress
anticonvuls
specif
parenter
malari
therapi
detail
discuss
anti
malaria
treatment
review
quinin
remain
first
line
treatment
sever
falciparum
malaria
intraven
administr
drug
requir
monitor
ecg
cardiac
function
travel
return
southeast
asia
quinin
resist
common
advic
regard
use
intraven
artesun
sought
specialist
centersextracorpor
therapi
sever
parasitemia
exchang
transfus
may
requir
renal
replac
therapi
may
necessari
present
advanc
shock
multiorgan
system
failur
mosf
manag
intracrani
hypertens
pleas
read
section
rais
intracrani
pressur
bacteri
mening
later
chapter
manag
similar
aureu
gramposit
coccu
group
cluster
respons
number
infect
rang
skin
sepsi
pneumonia
joint
infect
endocard
phage
transform
staphylococcu
produc
toxin
initi
syndrom
known
toxic
shock
syndrom
tss
came
light
menstrual
shock
syndrom
non
menstrual
form
also
identifi
associ
staphylococcu
sepsi
surgic
site
skin
joint
infect
staphylococc
pneumonia
syndrom
said
superantigen
mediat
toxin
protein
produc
staphylococcu
abl
crosslink
tcell
receptor
without
process
antigen
present
cell
apc
lead
uncontrol
cascad
cytokin
immun
system
regul
level
capillari
lead
inflamm
increas
permeabl
secondari
organ
dysfunct
renal
impair
cardiac
pulmonari
liver
dysfunct
clinic
manifest
skin
erythema
tachycardia
hypotens
hypoxia
critic
organ
dysfunct
initi
subtl
rapidli
develop
multi
organ
dysfunct
see
tabl
criterion
upon
diagnosi
staphylococc
toxic
shock
made
treatment
consist
recognit
process
drain
collect
pu
debrid
appropri
time
initi
larg
volum
fluid
resuscit
inotrop
support
support
fail
lung
oxygen
ventil
need
antistaphylococc
antibiot
administ
includ
antibiot
cover
methicillin
resist
staphylococcu
clindamycin
antiribosom
antibiot
bacteri
ribosom
theoret
advantag
reduc
amount
toxin
produc
prior
antibiot
induc
death
bacterium
intraven
immunoglobulin
ivig
treatment
sever
toxic
shock
progress
multisystem
dysfunct
proven
efficaci
toxic
shock
reduc
mortal
sever
diseas
thought
via
two
gener
mechan
first
bind
directli
toxin
second
immunomediatori
properti
major
criteria
requir
fever
orthostat
shock
rash
erythemat
earli
desquam
later
minor
criteria
three
requir
gastrointestin
vomit
diarrheamuscular
sever
myalgia
cpk
upper
limit
normalmuc
membran
vagin
oropharyng
conjunctiv
hyperemiaren
urea
creatinin
upper
limit
normal
urinalysi
wbc
per
highpow
fieldhepat
total
bilirubin
ast
alt
upper
limit
normalblood
platelet
count
disorient
chang
level
conscious
without
focal
note
fever
hypotens
absent
andabs
explanationsblood
cultur
neg
except
aureu
streptococc
toxic
shock
syndrom
analog
staphylocc
toxic
shock
syndrom
superantigen
mediat
toxin
relat
dysfunct
immun
system
group
betahemolyt
streptococcu
commonli
associ
streptococc
toxic
shock
syndrom
clinic
present
similar
staphylococc
toxic
shock
see
tabl
treatment
consist
appropri
antibiot
clindamycin
use
antimicrobi
antitoxin
produc
properti
previous
mention
ivig
role
reduc
mortal
sever
diseas
intens
care
therapi
consist
fluid
resuscit
larg
volum
support
organ
dysfunct
inotrop
ventil
renal
replac
therapi
hypotens
shock
plu
two
follow
scarlet
fever
rashabnorm
liver
function
testsren
insufficiencydissemin
intravascular
coagulopathi
dic
acut
respiratori
distress
syndrom
ard
soft
tissu
necrosi
definit
preced
requir
isol
group
streptococcu
normal
steril
bodi
site
probabl
preced
requir
isol
group
streptococcu
non
steril
bodi
site
necrot
soft
tissu
infect
aggress
soft
tissu
infect
caus
extens
necrosi
includ
necrot
cellul
fasciiti
myonecrosi
follow
clinic
find
may
present
erythema
discolor
skintens
edemadiscoloredgray
wound
dischargeblisterulcerskin
necrosiscrepitu
also
follow
system
sign
may
present
local
pain
tender
proport
physic
findingspain
tender
extend
past
margin
appar
affect
skin
areafeverpersist
tachycardiadiaphoresischang
sensoriumhypotens
necrot
fasciiti
surgic
emerg
caus
number
organ
group
betahemolyt
streptococci
streptococci
staphylococcu
clostridium
pseudomona
klebsiella
serratia
neisseria
escherichia
morganella
proteu
shigella
vibrio
salmonella
pasturella
enterobact
corynebacterium
cryptococcu
fusobacterium
peptococcu
eikenella
bacteroid
common
caus
agent
group
streptococcu
patholog
character
micro
angiopath
thrombosi
necrosi
along
superfici
deep
fascial
plane
ill
associ
breach
integu
superfici
infect
surgeri
trauma
non
steroid
antiinflammatori
drug
implic
pathogenesi
children
associ
varicella
chickenpox
infect
clinic
lesion
appear
either
pale
violac
discolor
often
edemat
may
crepitu
ga
form
bacteria
pain
tender
excess
expect
featur
concern
intensivist
physiolog
decompens
lead
rapid
cardiovascular
collaps
broadspectrum
appropri
antibiot
indic
mechan
ventil
cardiovascular
support
may
need
urgent
wide
surgic
debrid
affect
area
indic
case
streptococc
necrot
fasciiti
may
addit
benefit
human
immunoglobulin
ivig
therapi
though
subject
clinic
trial
given
high
mortal
rate
necrot
fasciiti
biolog
plausibl
consider
ivig
could
neutral
effect
streptococc
superantigen
use
justifi
treatment
use
vacuumassist
wound
closur
particularli
patient
larg
wound
debrid
hyperbar
oxygen
anecdot
evid
prodrom
mild
fever
uri
symptom
day
onset
stridor
stridor
characterist
harsh
dri
high
pitch
inspiratori
bark
seallik
cough
promin
usual
wors
night
children
voic
though
hoars
trismu
dyphagia
signific
drool
children
stridor
rest
admit
observ
sever
uao
admit
picu
children
croup
requir
hospit
usual
investig
need
administr
steroid
oral
rout
good
intramuscular
emerg
room
decreas
rate
hospit
hospit
children
croup
receiv
short
cours
oral
intraven
steroid
exampl
regimen
dexamethason
mgkg
ivpo
initi
dose
follow
mgkg
q
h
ivpo
inhal
nebul
epinephrin
solut
mlkg
mg
reduc
sever
obstruct
stridor
repeat
requir
child
must
observ
least
h
dose
nebul
epinephrin
effect
transient
decis
intub
child
croup
clinic
one
despit
maximum
medic
treatment
clinic
improv
perhap
deterior
decis
intub
made
least
consid
gentl
smooth
intub
use
tube
one
size
smaller
usual
age
child
perform
skill
experienc
practition
children
risk
accident
extub
need
proper
secur
ett
skill
nurs
care
adequ
sedat
airway
secur
clinician
extub
child
day
later
audibl
air
leak
develop
around
ett
fever
settl
fewer
fewer
physician
seen
even
one
case
epiglott
import
high
index
suspicion
febril
child
uao
follow
sign
highli
suspici
epiglott
usual
prodrom
sign
symptomsa
hour
high
fever
tachypneapain
swallow
henc
drool
commonreluct
speakth
child
look
ill
circumor
pallor
toxic
appearancether
minim
coughingstridor
lowpitch
muffl
like
snorechild
prefer
sit
forward
tripod
posit
mouth
open
reluct
move
head
neck
suspicion
clinic
ground
child
may
epiglott
make
child
lie
downdo
separ
child
parentdo
examin
throatdo
place
iv
cannulado
order
later
xray
neckdo
order
blood
workdo
transport
child
epiglott
hospit
unintubatedth
child
accompani
expert
difficult
airway
manag
oper
room
examin
anesthesia
secur
airway
need
techniqu
induct
anesthesia
beyond
scope
chapter
gener
inhal
method
perform
sit
posit
posit
comfort
child
child
lose
conscious
intraven
access
secur
rest
monitor
appli
laryngoscopi
intub
attempt
adequ
depth
anesthesia
obtain
blood
cultur
swab
inflam
epiglotti
sent
gener
cephalosporin
given
iv
place
back
picu
accident
extub
disastr
consequ
skill
tape
ett
nurs
care
adequ
anaelgesiased
emphas
usual
h
intraven
antibiot
patient
safe
extub
fever
subsid
presenc
leak
document
child
abl
swallow
child
drool
practition
prefer
reevalu
direct
laryngoscopi
patient
deepli
sedat
anesthet
caus
organ
prove
hib
famili
sibl
year
age
famili
immunocompromis
child
prophylaxi
rifampicin
provid
children
usual
high
fever
look
toxic
stridor
characterist
high
pitch
compos
inspiratori
expiratori
compon
cough
usual
promin
may
dysphonia
aphonia
drool
seen
bacteri
tracheiti
patient
risk
airway
obstruct
requir
appropri
antimicrobi
therapi
observ
intub
expert
warrant
communityacquir
pneumonia
oppos
nosocomi
hospit
acquir
pneumonia
common
pediatr
diagnosi
lead
admiss
hospit
intraven
antibiot
support
respiratori
therapi
pneumonia
mean
inflamm
lung
parenchyma
caus
infect
diagnosi
made
clinic
febril
child
respiratori
sign
symptom
evid
consolid
cxr
blood
cultur
frequent
fail
reveal
infect
organ
pneumonia
tracheal
aspir
reliabl
bronchoalveolar
lavag
bal
occas
lung
biopsi
requir
children
immunodefici
malign
undergo
therapi
common
exampl
bal
andor
lung
biopsi
may
necessari
rsvinfluenza
b
cparainfluenza
type
metapneumovirusadenovirusoth
rhinoviru
cmv
vzv
enteroviru
hsv
measl
pneumonia
aureu
h
influenza
pyogen
group
streptococcu
enter
gram
neg
klebsiella
e
coli
p
aeroginosa
mycoplasma
pneumonia
chlamydia
pneumonia
legionella
pneumonia
mycobacterium
tuberculosi
pneumonia
aureu
import
bacteri
pathogen
children
pneumonia
need
intens
care
admiss
gener
rule
truli
focal
diseas
confin
singl
lobe
like
due
bacteria
ill
child
unilater
pleural
effus
like
pneumonia
aureu
pneumonia
rout
acquir
infect
inhal
infect
particl
common
aspirationhematogen
invas
lower
respiratori
tract
virus
bacteria
lead
inflammatori
chang
character
migrat
neutrophil
alveoli
togeth
alveolar
macrophag
provok
product
inflammatori
exud
cellular
debri
lead
consolid
lung
parenchyma
surround
area
affect
atelectasi
high
concentr
inspir
oxygen
excess
work
breath
may
lead
exhaustionshock
hemodynam
instabilitychang
neurolog
statu
agit
alter
level
conscious
reason
failur
respond
treatment
pediatr
ward
outpati
develop
empyema
less
commonli
lung
abscessunderli
lung
diseas
bronchopulmonari
dysplasia
bpd
expremi
cystic
fibrosi
inhal
foreign
bodi
tracheobronchomalacia
post
tracheal
surgeri
infect
congenit
lung
cystdiagnos
undiagnos
immunodefici
state
primari
hiv
leukemia
children
neuromuscular
diseas
weak
spastic
muscular
dystrophi
myasthenia
spinal
muscular
atrophi
cerebr
palsyinappropri
antibiot
inappropri
low
dose
resist
bacterianon
bacteri
pneumonia
viral
pneumonia
altern
pathogen
tuberculosi
cultur
result
bal
blood
cultur
sputum
cultur
sensit
known
therapi
tailor
antibiot
sensit
caus
organ
empyema
commonli
seen
pneumonia
aureu
pneumonia
gener
chest
drain
need
use
fibrinolyt
surgeri
area
debat
local
advic
thorac
gener
surgeon
physician
respiratori
infecti
diseas
servic
soughtlung
abscess
aureu
pneumonia
group
streptococcu
k
pneumonia
p
aeroginosa
anaerob
organ
aspergillu
rapid
respons
intraven
antibiot
earli
percutan
drainag
ct
guidanc
prolong
cours
intraven
antibiot
indicatedpneumatocel
pneumothorax
air
leak
aureu
necrot
lung
infect
may
need
chest
drain
possibl
wean
posit
pressur
spontan
ventilationhu
associ
pneumonia
pneumonia
children
usual
sick
younger
may
associ
mening
major
need
temporari
renal
replac
therapi
picu
viru
caus
direct
damag
respiratori
epithelium
result
inflamm
increas
secret
small
airway
obstruct
area
hyperinfl
atelectasi
exist
simultan
throughout
lung
lead
ventil
perfus
vq
mismatch
hypoxia
hyperinfl
flatten
diaphragm
make
breath
less
effici
hydrat
nutrit
nasogastr
feed
infant
seem
need
immedi
ventilatori
support
intraven
fluidsoxygen
suction
nasal
nasopharyng
airway
frequent
provid
supplement
oxygen
via
nasal
cannula
head
box
keep
drug
routin
use
bronchodil
salbutamol
ipratropium
epinephrin
recommend
practic
respons
singl
dose
nebul
salbutamol
evalu
continu
improv
observedribavarin
shown
conclus
improv
outcomeantibiot
routin
recommend
except
bacteri
super
infectionsteroid
indic
hydrat
child
report
one
third
infant
hyponatremia
due
excess
level
adh
despit
high
concentr
supplement
apnea
irregular
respiratori
effortexcess
work
breath
lead
exhaust
inabl
settl
pauciti
spontan
movement
requir
respiratori
support
mani
infant
manag
noninvas
continu
posit
airway
pressur
cpap
cm
reduc
work
breath
improv
oxygen
suction
maintain
patenc
airway
crucial
import
satur
remain
low
andor
infant
continu
frequent
apnea
despit
provid
noninvas
ventilatori
support
intub
trachea
indicatedintub
usual
requir
sever
daysinadequ
humidif
inadequ
tracheal
suction
caus
endotrach
tube
blockag
lung
atelectasi
follow
increas
pressur
requirementsa
gener
rule
best
ventilatori
mode
one
assist
spontan
respiratori
effort
keep
child
respiratori
cough
effort
provid
enough
comfort
sedat
pressur
supportpeep
cpap
initi
cm
may
reduc
work
breathingappli
enough
peak
inspiratori
pressur
pip
achiev
visibl
chest
excurs
higher
pressur
cm
need
let
gradual
rise
mmhg
arteri
ph
permiss
hypercapnia
particular
issu
infant
congenit
heart
diseas
bronchiol
infant
left
right
shunt
frequent
viral
bacteri
respiratori
infect
higher
morbid
prolong
cours
bronchiolitisinf
palliat
singl
ventricl
physiolog
limit
cardiac
output
exampl
sever
valvar
aortic
stenosi
high
morbid
mortal
bronchiolitisbronchiol
viral
respiratori
infect
infant
congenit
heart
diseas
lead
oper
delay
increas
complic
post
cardiac
bypass
surgeri
eg
pulmonari
hypertens
infant
rsv
bronchiol
congenit
heart
diseas
await
surgeri
suggest
wait
week
proceed
bypass
surgeri
american
academi
pediatr
specif
recommend
prophylact
monthli
inject
rsv
monoclon
antibodi
risk
infant
cold
season
howev
use
approach
shown
aid
small
number
patient
myocard
inflammatori
diseas
heart
muscl
character
activ
phase
cellular
infiltr
myocardi
necrosi
howev
myocard
cellular
infiltr
littl
myonecrosi
case
myocard
thought
viral
etiolog
howev
virus
infrequ
isol
common
viral
caus
includ
enteroviru
famili
particularli
coxsackieviru
b
adenoviru
viral
caus
influenza
cmv
hsv
parvoviru
rubella
varicella
mump
hiv
ebv
myocard
number
non
viral
etiolog
infect
includ
bacteria
rickettsia
fungi
protozoa
pharmaceut
toxin
connect
tissueautoimmun
disord
typic
viral
myocard
begin
system
viral
ill
flulik
symptom
viru
infect
myocyt
immun
system
regul
thelper
cell
cytotox
cell
stimul
along
proinflammatori
cytokin
persist
viral
rna
product
myocyt
link
myocardi
tissu
damag
myocard
present
number
way
hospit
cardiac
arrestsudden
deathcardiogen
shock
may
mimic
sepsi
congest
heart
failur
increas
dyspnea
lethargi
dysrhythymia
bradycardia
tachycardia
whilst
sepsi
hypovolem
shock
common
cardiogen
shock
myocard
alway
differenti
sometim
acut
decompens
children
herald
abdomin
distens
vomit
teenag
may
complain
feel
impend
doom
sever
chest
discomfort
clinic
sign
tachycardiatachypnea
gallop
rhythm
hyperdynam
precordium
displac
apex
often
present
hepatomegali
older
children
elev
jugular
venou
pressur
jvp
usual
present
crackl
auscult
often
present
chest
older
children
chest
xray
cxr
may
show
enlarg
heart
pulmonari
venou
congest
alveolar
edema
kerley
b
line
case
pleural
effus
acut
myocard
heart
may
often
look
normal
size
cxr
ecg
use
assess
underli
rhythm
assess
ischemia
subtl
ecg
chang
sometim
evid
myocard
stt
chang
reduc
qr
voltag
widen
qr
echocardiographi
absolut
necessari
assess
structur
function
heart
assess
pericardi
effus
involv
appropri
specialist
import
cardiologist
intensivist
cardiothorac
surgeon
work
cooper
manag
stabil
patient
treatment
myocard
larg
support
immunomodul
use
steroid
intraven
immunoglobulin
immunosuppress
agent
controversi
identifi
modifi
contributor
ie
toxin
drug
crucial
import
support
therapi
heart
failur
associ
myocard
rang
diuret
afterload
reduct
addit
inotrop
support
place
patient
mechan
circulatori
support
dopamin
dobutamin
increas
contractil
also
heart
rate
myocardi
oxygen
consumpt
milrinon
intraven
phosphodiesteras
inhibitor
improv
contractil
time
reduc
afterload
enoximon
oral
phosphodiesteras
inhibitor
avail
europ
north
america
levosimendan
calcium
sensit
improv
contractil
limit
avail
world
wide
posit
intrathorac
pressur
given
noninvas
via
face
mask
cpap
reduc
lv
afterload
may
improv
cardiac
output
set
lv
dysfunct
fail
medic
therapi
deterior
function
usual
indic
need
extracorpor
support
ultim
heart
transplant
mechan
support
ecl
berlin
heart
frequent
use
bridg
recoveri
transplant
complet
review
endocard
review
cardiolog
chapter
book
major
reason
child
endocard
may
need
admiss
picu
congest
heart
failur
due
worsen
valvar
regurgitationcongest
heart
failur
abrupt
onset
due
valv
apparatu
ruptureperfor
dehisc
prosthet
valvesystem
pulmonari
arteri
shunt
obstructionarrhythmiaren
failureembol
event
tobrainheartlungsbowelextrem
therapi
depend
hemodynam
statu
patient
toxiclook
child
physiolog
sign
symptom
tamponad
transfer
urgent
catheter
laboratori
intens
care
unit
percutan
drainag
pericardi
collect
sometim
pu
pericardium
thick
organ
esp
h
influenza
percutan
drainag
may
suffici
child
need
open
surgic
drainag
tamponad
physiolog
administr
fluid
bolus
temporarili
increas
intracardiac
fill
stabil
patient
definit
treatment
percutan
surgic
drainag
perform
broadspectrum
intraven
antibiot
good
antistaphyloccc
coverag
commenc
promptli
purul
pericard
suspect
surgic
wound
infect
cardiac
surgeri
categor
superfici
cellul
deep
mediastin
patient
usual
present
day
procedur
may
occur
month
initi
oper
import
sign
erythema
indur
surgic
incis
child
may
irrit
mild
fever
may
leukocytosi
left
shift
elev
inflammatori
marker
creactiv
protein
crp
erythrocyt
sediment
rate
esr
addit
wound
erythema
without
purul
discharg
may
sign
sternal
instabl
crepitu
direct
pressur
sternum
diagnosi
nevertheless
clinic
one
reli
high
index
suspicion
risk
factor
neonat
long
cardiopulmonari
bypass
time
delay
sternal
closur
reexplor
chest
postop
bleed
common
organ
associ
sternal
wound
infect
aureu
epidermidi
enterococcu
speci
candida
speci
antibiot
treatment
begin
soon
sternal
wound
infect
suspect
wound
swab
sent
blood
cultur
sent
peripher
central
venou
site
whenev
possibl
initi
antibiot
regimen
consist
broadspectrum
gramposit
antistaphylococc
coverag
addit
gramneg
coverag
patient
septic
mediastin
suspect
rapid
improv
patient
deterior
sternal
wound
may
need
surgic
explor
debrid
antibiot
given
day
week
cellul
week
deep
wound
infect
mening
inflamm
leptomening
brain
review
asept
mening
also
includ
viral
caus
mening
pleas
look
neurolog
infecti
diseas
chapter
textbook
suffic
mention
patient
asept
mening
usual
sick
purul
mening
csf
abnorm
promin
patient
bacteri
mening
number
reason
requir
intens
care
common
clinic
scenario
coma
seizur
local
inflammatori
respons
bacteria
multipli
csf
involv
polymorphonuclear
leukocyt
endothelium
complement
cytokin
result
alter
cerebr
blood
flow
venou
drainag
vascular
inflamm
obstruct
csf
flow
reabsorpt
infect
within
mening
may
extend
surround
brain
parenchyma
commonest
bacteria
pneumonia
n
meningitidi
h
infuenza
neonat
period
like
caus
organ
differ
group
b
streptococcu
l
monocytogen
gramneg
bacilli
commonest
profil
modifi
depend
local
vaccin
polici
socioeconom
statu
children
area
localregion
epidem
diseas
none
less
intens
care
manag
similar
broadspectrum
cn
penetr
antibiot
narrow
spectrum
antibiot
cover
result
cultur
blood
csf
known
antibiot
high
csfbrain
tissu
penetr
must
alway
use
area
high
incid
pneumonia
penicillin
resist
includ
unit
state
empir
therapi
communityonset
bacteri
mening
vancomycin
gener
cephalosporinappropri
level
observ
intens
care
support
depend
level
conscious
physiolog
derangementmanag
rais
intracrani
pressur
icp
head
midlin
obstruct
jugular
venou
returnsed
analgesia
intub
monitor
patientsaggress
control
fever
seizureshyperosmolar
agent
mannitol
sodium
chloridein
intub
patient
keep
low
normal
rang
mmhg
use
hyperventil
temporarili
acut
rise
icpcsf
drainag
via
extraventricular
drain
rare
decompress
craniectomi
usual
discuss
infecti
diseas
expert
neurosurgeon
acut
complic
bacteri
mening
hyponatremia
serum
sodium
micromolel
usual
due
syndrom
inappropri
secret
antidiuret
hormon
siadh
hyponatremia
low
serum
osmolar
without
sign
hypovolemia
hyponatremia
caus
convuls
cerebr
salt
wast
much
rarer
condit
give
hyponatremia
sign
volum
contract
siadh
treat
free
water
restrict
cerebr
salt
wast
treat
sodium
either
iv
po
supplement
hyponatrem
child
convuls
give
nacl
mlkg
intraven
import
note
chang
serum
sodium
henc
serum
osmolar
import
case
absolut
serum
sodium
sudden
drop
serum
sodium
greater
micromoleh
treat
hyperton
salineseizur
convuls
occur
earli
cours
purul
mening
usual
gener
less
prognost
signific
occur
later
etiolog
convuls
mening
follow
brain
edema
diffus
ischemia
hyponatremia
subdur
collect
sinu
venou
thrombosi
focal
infarctionsubdur
effus
complic
seen
commonli
neonat
infant
good
practic
measur
head
circumfer
daili
infant
mening
diagnosi
made
confirm
neuroimag
effus
larg
associ
focal
sign
convuls
sign
increas
intracrani
pressur
neurosurg
consult
necessaryobstruct
hydrocephalu
obstruct
hydrocephalu
occur
pu
often
high
protein
content
ventricl
block
outflow
csf
situat
occur
frequent
small
infant
neonat
similar
mening
seizur
focal
gener
sign
coma
common
present
list
differenti
diagnosi
long
includ
asept
mening
post
infecti
enceph
noninfecti
encephalopathi
metabol
vascular
demyelin
diseas
tumor
frequent
caus
acut
enceph
includ
enterovirus
hsv
vzv
ebv
adenoviru
influenza
viru
pneumonia
mump
measl
rubella
infect
rare
seen
develop
countri
mani
part
world
arbovirus
major
caus
endem
encephalitid
tuberculosi
alway
high
list
differenti
diagnosi
develop
countri
diagnosi
csf
complet
normal
usual
contain
mainli
lymphocyt
mildli
increas
protein
level
mildli
reduc
normal
glucos
level
children
hsv
enceph
csf
may
contain
red
blood
cell
csf
addit
cell
count
chemistri
cultur
sent
pcr
viral
agent
csf
pcr
help
number
infecti
encephalopathi
exampl
pneumonia
mycobacterium
cmv
ebv
vzv
organ
may
cultur
csf
brain
imag
ct
mri
help
diagnosi
hsv
enceph
may
focal
edema
enhanc
seen
tempor
area
rel
specif
hsv
infect
brain
electroencephalogram
may
show
focal
period
epileptiform
activ
frontal
tempor
part
brain
common
hsv
diseas
diffus
slow
wave
gener
cerebr
cortex
may
also
seen
may
either
repres
enceph
secondari
sed
anticonvuls
use
picu
primari
use
eeg
manag
seizur
final
etiolog
diagnosi
clear
patient
deterior
despit
treatment
brain
biopsi
may
perform
treatment
larg
support
mening
consist
appropri
antimicrobi
antivir
therapi
delay
start
acyclovir
hsv
suspect
consid
dose
mgkgday
day
pneumonia
suspect
antibiot
good
penetr
brain
ciprofloxacin
azithromycin
use
addit
manag
includ
airway
protect
coma
seizur
medic
surgic
therapi
manag
intracrani
hypertens
discuss
adher
adem
acut
sub
acut
inflammatori
demyelin
diseas
cn
brain
spinal
cord
contrast
multipl
sclerosi
monophas
ill
adem
consid
parainfecti
diseas
precipit
includ
infect
upper
respiratori
tract
virus
influenza
group
streptococcu
ebv
vzv
measl
mump
rubella
mycoplasma
clinic
present
may
involv
fever
seizur
constel
neurolog
phenomena
commonli
coma
focal
neurolog
deficit
alter
person
behavior
often
recent
viral
infect
present
histori
lumbar
punctur
done
exclud
infect
csf
may
normal
white
cell
count
mild
pleocytosi
mainli
lymphocyt
mild
signific
protein
elev
cultur
pcr
neg
neuroimag
main
diagnost
tool
adem
mri
modal
choic
ct
normal
case
typic
mri
find
multipl
dissemin
asymmetr
hyperintens
lesion
flair
white
matter
basal
ganglia
cerebrum
involv
cerebellum
treatment
continu
antibiot
antivir
final
csf
cultur
pcr
result
confirm
neg
infect
rule
methylprednisolon
puls
dose
mgkgday
maximum
g
day
follow
oral
prednisolon
mgkgday
week
follow
week
wean
regimen
plasma
exchang
ivig
relaps
refractori
adem
gb
immunemedi
polyneuropathi
usual
preced
viral
bacteri
infect
respiratori
gi
tract
week
prior
present
gb
common
caus
acut
paralysi
develop
countri
character
progress
ascend
symmetr
motor
weak
loss
reflex
sensori
symptom
extrem
pain
paresthesia
autonom
irregular
tachycardia
bradycardia
hypertens
hypotens
arrhythmia
promin
usual
sensori
deficit
physic
examin
infect
known
preced
onset
paralysi
cmv
ebv
vzv
campylobact
jejuni
mycobacterium
tuberculosi
hiv
pneumonia
pathogenesi
involv
immun
respons
infecti
agent
compon
crossreact
peripher
nervou
system
diagnosi
clinic
aid
csf
electrophysiolog
test
csf
show
high
protein
content
lownorm
white
cell
count
may
miss
lumbar
punctur
done
earli
first
week
ill
electrophysiolog
show
decreas
conduct
veloc
peripher
nerv
treatment
ivig
gkgday
day
plasma
exchang
two
cours
mild
gb
four
five
cours
sever
ill
corticosteroid
demonstr
effect
gb
recommend
indic
picu
admiss
respiratori
supportfor
plasma
exchangeautonom
instabl
hypo
hypertens
arrhythmia
botul
toxin
mediat
diseas
caus
c
botulinum
symptom
start
hour
day
exposur
toxin
cranial
nerv
involv
initi
difficulti
swallow
abnorm
speech
abnorm
cri
infant
eye
movement
ptosi
symptom
may
includ
nausea
vomit
constip
abdomin
distens
ill
progress
caus
paralysi
extrem
respiratori
muscl
variou
degre
infant
diseas
mild
hypotonia
constip
main
find
also
infant
sometim
histori
ingest
honey
onset
symptom
honey
may
contain
spore
c
botulinum
diagnosi
made
combin
clinic
find
electromyographi
stool
botulinum
toxin
serum
serolog
confirmatori
take
time
treatment
antitoxin
remov
circul
toxin
affect
toxin
alreadi
present
neuromuscular
junction
specif
botulinum
immunoglobulin
readili
avail
world
wide
cost
prohibit
lot
countri
costbenefit
analysi
favor
patient
requir
mechan
ventil
penicillin
metronidazol
given
erad
sourc
toxin
product
aminoglycosid
steroid
given
may
worsen
neurosmuscular
transmiss
defect
increas
muscular
weak
sourc
c
botulinum
wound
ie
wound
botul
need
surgic
debrid
indic
admiss
picu
respiratori
supportautonom
instabl
neutropenia
defin
absolut
neutrophil
count
anc
anc
pmn
band
count
gener
associ
cancer
treatment
risk
infect
particularli
high
rapid
drop
ancanc
profound
neutropenia
prolong
neutropenia
fever
neutropen
patient
defin
oraltympan
membran
temperatur
two
repeat
measur
h
period
one
measur
portal
entri
infecti
agent
usual
oral
mucosa
gut
upperlow
respiratori
tract
central
vascular
line
common
organ
gramposit
cocci
aureu
epidermidi
strep
viridan
gramneg
bacilli
e
coli
k
pneumonia
p
aeroginosa
fungi
candida
aspergillu
recent
spectrum
pathogen
begun
chang
emerg
gramneg
fungal
infect
like
due
increas
resist
pathogen
face
use
broadspectrum
antibiot
intens
therapi
highdos
chemotherapi
stem
cell
transplant
prolong
neutropenia
singl
import
risk
factor
fungal
infect
durat
neutropenia
standard
practic
start
antibiot
child
anc
febril
initi
empir
therapi
febril
neutropenia
consist
antibiot
aminoglycosid
plu
glycopeptid
coagulas
neg
staph
enterococcu
suspect
isol
child
shock
endoprosthesi
vascular
tunnel
infect
patient
histori
arabinosidec
administr
sever
mucos
strep
viridan
infect
highli
suspect
vancomycin
ad
perian
tender
present
add
anaerob
coverag
metronidazol
clindamycin
day
fever
neutropenia
ad
antifung
usual
practic
oncologist
infant
sever
combin
tcell
immun
defici
usual
present
earli
first
month
defect
cellmedi
immun
result
congenit
disord
digeorg
syndrom
sever
combin
immunodefici
diseas
scid
syndrom
secondari
lymphoma
immunosuppress
medic
chronic
ill
acut
viral
infect
measl
pertussi
also
known
decreas
patient
cellmedi
immun
typic
infect
pneumocysti
jiroveci
pneumonia
formerli
carinii
cmv
pneumon
rsv
pneumon
dissemin
enterovir
infect
invas
fungal
infect
patient
highli
suscept
infect
intracellular
organ
salmonella
listeria
mycobacteria
herp
famili
virus
cmv
ebv
hsv
well
fungi
protozoa
older
children
secondari
immunodefici
infect
tend
reactiv
diseas
children
chronic
mucocutan
candidiasi
chronic
granulomat
diseas
typic
present
earli
life
recurr
candida
staphylococc
infect
neonat
adhes
molecul
defici
usual
present
delay
separ
umbil
cord
stump
increas
polymorphonuclear
count
increas
incid
bacteri
infect
children
primari
humor
immun
defici
usual
present
month
year
age
onset
consist
time
level
placent
transfer
matern
antibodi
igg
declin
defect
well
complement
defici
asplenia
commonli
associ
infect
encapsul
microorgan
h
influenza
n
meningitid
pneumonia
although
patient
condit
mainli
suscept
bacteri
infect
involv
upper
lower
respiratori
tract
protract
diarrhea
giardia
echoviru
defect
late
complement
compon
attack
compon
prone
recurr
neisseria
infect
children
earli
complement
defect
usual
autoimmun
rheumatolog
manifest
fulmin
meningococcemia
also
associ
properdin
defici
altern
complement
pathway
hsct
establish
treatment
host
immunolog
metabol
hematolog
neoplast
disord
stem
cell
may
obtain
patient
autolog
altern
hlacompat
relat
unrel
donor
allogen
littl
risk
acut
chronic
graft
versu
host
diseas
gvhd
autolog
hsct
current
three
sourc
stem
cell
bone
marrow
peripher
blood
umbil
cord
blood
gener
umbil
cord
stem
cell
transplant
speed
engraft
lower
risk
gvhd
peripher
blood
stem
cell
transplant
engraft
occur
faster
risk
gvhd
also
higher
bone
marrow
stem
cell
transplant
speed
engraft
risk
gvhd
somewher
two
sourc
unrel
umbil
cord
blood
tcell
deplet
bone
marrow
blood
stem
cell
transplant
risk
graft
failur
higher
higher
risk
infect
occurr
gvhd
graft
failur
condit
regimen
use
prepar
patient
gener
consist
highdos
chemotherapi
without
region
total
bodi
irradi
post
transplant
period
pancytopenia
though
neutrophil
count
usual
normal
week
unusu
patient
need
red
cell
platelet
transfus
much
longer
risk
infect
influenc
rapid
myeloid
recoveri
rate
lymphoid
reconstitut
speed
restor
adequ
immun
function
highli
variabl
stem
cell
sourc
hla
compat
purg
tcell
deplet
graft
prior
transplant
sever
gvhd
import
factor
earli
posttranspl
period
first
day
transplant
center
employ
prophylact
measur
reduc
risk
infect
measur
vari
differ
center
includ
prophylact
antibiot
pcp
candida
hsv
cmv
administr
ivigenvironment
precaut
isol
barrier
nurs
earli
posttranspl
period
patient
suscept
infect
caus
gramneg
gramposit
organ
fungi
higher
risk
cmv
pneumon
patient
gvhd
larg
due
need
immunosuppress
treatment
cmv
neg
recipi
receiv
transplant
cmv
posit
donor
highest
risk
cmv
pneumon
children
undergon
hsct
admit
picu
particularli
poor
prognosi
pneumonia
mechan
ventil
need
renal
replac
therapi
especi
poor
prognost
factor
septic
shock
line
sepsi
best
prognosi
addit
bacteria
commonli
isol
organ
cmv
rsv
adenoviru
candida
aspergillu
pcp
recent
report
great
ormond
street
hospit
london
uk
patient
surviv
discharg
similar
children
receiv
hsct
children
receiv
solid
organ
transplant
prone
infect
transplant
main
differ
patient
solid
organ
transplant
usual
less
immunosuppress
hsct
patient
risk
immun
reconstitut
syndrom
associ
inflammatori
infecti
complic
howev
risk
surgeryrel
complic
postsurg
infect
issu
wound
infect
bacteremia
atelectasispneumonia
urinari
tract
infect
infect
transplant
organ
due
latent
colon
organ
present
either
donor
recipi
lead
invas
widespread
diseas
immun
suppress
posttranspl
recipi
exampl
child
cystic
fibrosi
colon
pseudomona
speci
colon
b
cepacia
particularli
risk
develop
resist
infect
post
lung
combin
heartlung
transplantschildren
receiv
solid
organ
transplant
risk
reactiv
latent
infect
cmv
unlik
hsct
patient
commonli
present
cmv
pneumon
recipi
solid
organ
transplant
cmv
diseas
depend
site
viru
latent
organ
transplant
lung
heartlung
liver
transplant
patient
vulner
system
diseas
cmv
infect
precipit
reject
increas
vulner
infect
fungal
infectionsebvassoci
post
transplant
lymphoprolif
disord
ptld
potenti
fatal
complic
solid
organ
transplant
risk
ptld
higher
children
ebv
seroneg
prior
sot
ebvrel
infect
sot
patient
may
present
sever
differ
way
asymptomat
nonspecif
viral
syndrom
mononucleosi
syndrom
ptld
latter
spectrum
fever
lymphadenopathi
diarrhea
full
blown
lymphoma
tissu
biopsi
necessari
establish
diagnosi
ptld
mainstay
therapi
consist
decreas
immunosuppress
chemotherapi
biolog
treatment
monoclon
antibodi
use
major
case
p
jiroveci
pneumonia
present
first
month
life
usual
children
quit
hypoxem
high
fever
uncommon
compar
bacteri
pneumonia
diffus
bilater
air
space
interstiti
involv
chest
xray
occasion
ground
glass
appear
hiv
posit
patient
bilater
diffus
parenchym
interstiti
infiltr
cxr
develop
pneumothorax
suggest
p
jiroveci
infect
diagnosi
bronchoalveolar
lavag
bal
even
child
develop
pneumocysti
prophylact
therapi
highdos
intraven
trimethoprimsulfamethoxazol
start
prophylaxi
may
fail
poor
complianc
one
suspect
drug
resist
agent
use
pentamidin
dapson
methylprednisolon
mgkgday
divid
four
dose
administ
moder
sever
case
practic
children
pneumocysti
admit
picu
day
taper
untreat
univers
fatal
proper
therapi
mortal
less
risk
factor
mortal
sever
respiratori
failur
sever
immunosuppress
lip
children
aid
associ
increas
risk
lower
respiratori
tract
infect
includ
bronchiectatsi
condit
produc
sever
ventilationperfus
mismatch
hypoxemia
may
also
asymptomat
cxr
show
diffus
infiltr
hilar
lymphadenopathi
persist
month
despit
antibiot
therapi
usual
cxr
chang
wors
clinic
symptom
lip
relat
ebv
infect
exagger
immunolog
respons
inhal
circul
antigen
steroid
use
treatment
symptomat
lip
coexist
hiv
tb
acceler
cours
infect
risk
miliari
extra
pulmonari
tb
higher
children
aid
cours
like
sever
rapid
child
hiv
infect
five
ten
time
risk
activ
tb
countri
high
preval
tuberculosi
suggest
bcg
vaccin
neonat
birth
childinf
clinic
aid
treatment
tb
pleas
refer
chapter
book
mac
produc
system
ill
children
infect
hiv
character
fever
chronic
diarrhea
abdomin
pain
malabsorpt
lymphadenopathi
obstruct
jaundic
mac
usual
would
present
signific
lung
diseas
children
iri
occur
week
initi
specif
antihiv
treatment
may
occas
sever
enough
caus
respiratori
failur
warrant
admiss
icu
though
also
indic
latent
incipi
mycobacteri
diseas
iri
diagnosi
exclus
requir
bal
possibl
transbronchi
biopsi
manag
usual
corticosteroid
sepsi
respiratori
failur
condit
may
bring
child
aid
intens
care
unit
name
common
one
cn
infect
bacteri
mycobacterium
fungi
cryptococcu
virus
rare
cn
toxoplasmosi
acut
hiv
encephalopathyhivrel
cardiomyopathysever
diarrhea
shock
due
cryptosporidium
microorganismsliv
failur
due
infect
drugscompl
antivir
medic
acut
pancreat
acut
liver
failur
syndrom
import
aspect
care
children
picu
staff
risk
exposur
bodi
fluid
needl
stick
injuri
univers
exposur
precaut
strictli
adher
imper
staff
awar
guidelin
procedur
exposur
biolog
fluid
institut
seek
advic
occup
health
depart
immedi
expos
increas
number
immunocompromis
children
fungal
viral
infect
admit
pediatr
intens
care
unit
common
antifung
antivir
medic
use
infect
briefli
review
complet
review
topic
reader
refer
chapter
individu
fungal
viral
infect
book
increasingli
system
fungal
infect
becom
signific
morbid
mortal
immunocompromis
patient
intens
care
unit
factor
associ
increas
use
potent
broadspectrum
antibacteri
agentsprolong
sever
neutropeniaprolong
sever
immun
dysfunct
primari
secondari
central
venou
line
invas
devicestot
parenter
nutrit
tpn
common
fungal
pathogen
caus
system
ill
critic
ill
children
candida
aspergillu
speci
recent
year
increas
import
uncommon
fungal
pathogen
nonalbican
candida
speci
fusarium
speci
trichosporon
speci
dematiac
fungi
immunocompromis
patient
posit
fungal
cultur
central
venou
line
current
guidelin
strongli
advoc
remov
line
tradit
invas
candidiasi
amphotericin
b
amb
firstlin
drug
use
howev
intraven
flucanozol
itraconazol
could
consid
nonneutropen
patient
posit
c
albican
candida
speci
fluconazol
effect
amb
empir
treatment
prolong
febril
neutropen
patient
day
amb
start
clinic
trial
shown
liposom
prepar
amphotericin
b
lamb
similar
better
efficaci
compar
convent
amb
prepar
author
recommend
liposom
prepar
amphotericin
prefer
firstlin
treatment
unfortun
high
cost
prohibit
mani
part
world
gener
lamb
agent
caus
less
fever
rigor
nausea
vomit
also
less
nephrotox
voriconazol
second
gener
triazol
use
empir
treatment
febril
neutropen
patient
place
lamb
patient
invas
aspergillosi
shown
initi
therapi
voriconazol
lead
better
respons
improv
surviv
fewer
side
effect
echinocandin
caspofungin
use
combin
amb
voriconazol
resist
case
invas
aspergillosi
persist
fever
micafungin
anidulafungin
two
agent
famili
antifiung
old
new
larg
potenti
side
effect
interact
clinician
need
awar
specif
profil
drug
use
antimicrobi
famili
common
agent
like
use
intens
care
unit
hiv
drug
discuss
pleas
refer
chapter
hiv
detail
discuss
agent
two
main
group
antivir
agent
inhibitor
viral
replic
inhibitor
viral
assembl
releas
central
venou
line
cvl
use
provid
secur
intraven
access
administr
medic
vasopressor
inotrop
monitor
pressur
blood
oxygen
satur
intraven
nutrit
survey
picu
unit
state
rate
cvl
infect
per
catheterday
neonat
correspond
figur
per
catheterday
europ
cvl
infect
occur
rate
infect
per
catheterday
measur
taken
time
insert
cvl
significantli
reduc
incid
infect
strict
asept
techniqu
gownsglovesmask
wide
steril
field
use
chlorhexidin
oppos
povodineiodin
minim
trauma
use
ultrasound
experienc
oper
import
factor
time
insert
chlorhexidin
disk
topic
place
upon
skin
insert
site
antibiot
impregn
line
use
unit
proven
valu
cuf
tunnel
line
hickman
line
portacath
line
picc
peripher
insert
central
cathet
significantli
lower
rate
infect
standard
central
line
insert
intens
care
long
term
therapi
week
requir
consider
undertaken
insert
one
type
line
site
insert
import
femor
vein
easi
cannul
fewest
insert
complic
howev
like
becom
infect
thrombos
good
temporari
line
earli
consider
given
remov
andor
reposit
access
prevent
central
line
infect
minim
open
line
daili
basi
import
asepsi
line
port
prior
use
alcohol
chlorhexiden
critic
import
ultim
reduc
infect
rate
line
kept
briefest
time
possibl
difficulti
insert
type
ongo
therapi
come
costbenefit
analysi
suspicion
central
venou
line
becom
infect
blood
cultur
drawn
line
peripher
punctur
broadspectrum
antibiot
cover
bacteria
vancomycin
gentamicin
exampl
commenc
line
remov
possibl
attempt
steril
line
may
made
circumst
line
preciou
easili
replac
involv
altern
infus
antibiot
lumen
use
antibiot
lock
defin
respiratori
infect
occur
h
post
admiss
mechan
ventil
respiratori
infect
defin
feverhypothermia
crackl
physic
exam
new
respiratori
infiltr
cxr
deterior
ventilatori
statu
tachypnea
cough
deterior
ga
exchang
elev
depress
white
cell
count
may
may
presenc
bacteri
isol
steril
respiratori
sampl
ie
bal
age
specif
criteria
diagnosi
vap
cdc
produc
document
list
specif
criteria
found
http
incid
vap
picu
per
ventilatorday
diagnosi
vap
challeng
controversi
number
simpl
intervent
reduc
incid
vap
elev
head
bed
tube
depend
posit
ventil
tube
avoid
aspirationremov
excess
condensatelimit
frequenc
tube
chang
unless
requir
suction
limit
amount
salin
lavag
suctioningsteril
techniqu
glove
steril
cathet
gownsmask
eye
wear
protect
staff
mouth
care
frequent
mouth
care
chlorhexidenebas
washfeed
earli
institut
feedingavoid
gastric
distensionlimit
use
antacid
therapi
high
risk
patient
ie
burn
head
injuri
avoidlimit
antibiot
therapi
minim
chanc
colon
antibiot
resist
flora
urinari
tract
infect
directli
proport
length
time
foley
cathet
place
frequent
patient
antibiot
suppress
urinari
infect
howev
virtual
intens
care
patient
urinari
cathet
acquir
urinari
sepsi
stay
prolong
hospit
acquir
uti
occur
catheter
children
best
intervent
central
line
earli
remov
cathet
strict
measur
urinari
output
need
likelihood
urinari
retent
due
ill
drug
issu
cathet
remov
intermitt
catheter
consid
intervent
avoid
perman
foley
cathet
retent
issu
longer
term
patient
icu
patient
develop
fever
unexplain
sepsi
mandatori
urin
specimen
sent
microscopi
cultur
especi
import
patient
cathet
urinari
sepsi
proven
consider
cathet
remov
given
broadspectrum
antibiot
cover
spectrum
bacteria
list
commenc
antibiot
specif
weight
cover
gramneg
bacteria
common
surgic
site
infect
less
frequent
infect
none
less
import
sourc
infecti
morbid
wound
dirti
contamin
traumat
soil
wound
contamin
peritoneum
perfor
append
broadspectrum
antibiot
commenc
high
dose
time
appropri
surgic
manag
undertaken
deal
contamin
wound
surgic
team
usual
offer
guidanc
issu
wound
clean
exampl
surgic
incis
surgic
team
gener
prefer
antibiot
prophylaxi
commonli
second
gener
cephalosporin
use
given
time
oper
defin
limit
time
thereaft
prolong
prophylaxi
shown
prevent
inevit
wound
infect
promot
emerg
multipl
antibiot
resist
wound
becom
infect
intens
care
unit
swab
taken
discharg
surgic
review
initi
wound
dress
frequent
chang
appropri
antibiot
commenc
open
wound
drainagedebrid
infect
tissu
respons
manag
surgic
team
intens
care
unit
abil
isol
airborn
bodi
fluid
infecti
organ
simpl
hand
wash
import
examin
patient
attend
bed
side
practic
alcoholbas
hand
gel
use
simpl
hand
wash
graduat
appropri
degre
isol
infect
control
process
undertaken
ie
gown
glove
respiratori
protect
mask
increas
filter
abil
full
respir
neg
pressur
room
antechamb
usual
reserv
respiratori
isol
protect
staff
patient
posit
pressur
room
protect
isol
patient
immunocompromis
neg
pressur
isol
strict
barrier
isol
reserv
highli
infecti
pathogen
sar
ebola
viru
exampl
may
necessari
intens
care
staff
strictli
adher
hand
wash
practic
chlorhexidin
base
product
unfortun
case
medic
staff
often
worst
offend
regard
activ
repeat
awar
campaign
carri
reinforc
basic
import
healthcar
relat
activ
sever
infecti
process
common
reason
admiss
pediatr
intens
care
unit
children
picu
risk
develop
sever
infect
increasingli
children
dysfunct
immun
system
surviv
primari
ill
admit
picu
sever
infect
secondari
immun
defici
common
cours
prolong
critic
ill
rapid
sampl
bodi
fluid
commenc
broadspectrum
antibiot
cover
utmost
import
shown
even
min
delay
start
appropri
antibiot
associ
increas
mortal
reason
believ
anatom
sourc
infect
collect
pu
infect
central
venou
line
infect
prosthesi
etc
often
antibiot
would
achiev
effect
sourc
infect
dealt
effect
surgic
evacuationremov
drainag
optim
hemodynam
statu
patient
oxygen
deliveri
address
preload
load
contractil
start
moment
one
consid
diagnosi
sepsi
sever
life
threaten
infect
diagnost
therapeut
intervent
go
hand
hand
start
parallel
initi
encount
patient
vital
everi
unit
updat
knowledg
preval
sensit
micro
organ
preval
commun
hospit
colleagu
clinic
microbiolog
infecti
diseas
depart
invalu
member
picu
team
deal
issu
prophylact
measur
effect
hand
wash
observ
strict
steril
place
central
venou
line
measur
reduc
incid
vap
discontinu
invas
line
cathet
indic
anymor
adher
univers
exposur
precaut
implement
monitor
audit
regularli
save
live
money
much
expens
intervent
effect
antibiot
stewardship
tailor
antibiot
coverag
sensit
caus
organ
known
discontinu
broadspectrum
antibiot
soon
clinic
prudent
decreas
burden
antimicrobi
resist
intens
care
unit
